Multidisciplinary lifestyle interventions for neurological disorders during the Silent phase (MINDS) study: a multi-omics randomized controlled trial protocol.
Alzheimer’s disease
Biomarkers
Epilepsy
Lifestyle interventions
Parkinson’s Disease
Randomized controlled trial
Stroke
Journal
Neurological research and practice
ISSN: 2524-3489
Titre abrégé: Neurol Res Pract
Pays: England
ID NLM: 101767802
Informations de publication
Date de publication:
01 Aug 2024
01 Aug 2024
Historique:
received:
24
05
2024
accepted:
02
07
2024
medline:
1
8
2024
pubmed:
1
8
2024
entrez:
31
7
2024
Statut:
epublish
Résumé
Given the prevalence and staggering cost of neurological disorders, there is dire need for effective early detection and intervention tools. Emerging evidence suggests that multidisciplinary lifestyle interventions (MLI) may mitigate the risk and progression of neurological disorders. The objectives of this protocol are (1) to test the impact of MLI on the progression of neurological disorders and (2) to identify multi-omic biomarkers for early stages of neurological disease and the impact of MLIs on these biomarkers. We present the Multidisciplinary lifestyle Interventions for Neurological Disorders during the Silent phase (MINDS) protocol, a randomized controlled trial of MLI in neurologically healthy older adults (≥ 50 years old) exhibiting elevated risk for common neurological disorders: stroke, epilepsy, Parkinson's Disease, or Alzheimer's disease and related dementias. Participants will be randomly assigned to intervention (n = 100) or control (n = 100) groups. The intervention group will receive 3 months of weekly 2-hour sessions on diet education, yoga, music therapy, and cognitive skills training. The participants' neurological health and engagement in relevant lifestyle practices will be assessed at regular intervals for 12 months. Neuroimaging and samples for multi-omic analyses will be collected at baseline, and at 3 months and 12 months after enrollment. Primary outcomes will be signs of progression of the neurological disorder risk that qualified them for study enrollment or a clinical diagnosis of the disorder. Secondary and exploratory outcomes will be based on self-reported health and multi-omic data. Data analysis will include between-group and longitudinal within-group analyses. The MINDS protocol and trial aims to clarify the impact of MLI on the progression of neurological disorder risk or diagnosis in older adults and to identify biomarkers that can be used to confirm MLI efficacy. The ability to validate the impact of MLI on neurological disorder progression based on biomarker data allows the identification of individuals most likely to benefit from such therapies in the early stages of neurological disease. The trial is registered on the National Institutes of Health (NIH) ClinicalTrials.gov (NCT05984056) site. It was registered on August 2nd, 2023. The trial has full approval of the Cleveland Clinic Internal Review Board.
Identifiants
pubmed: 39085927
doi: 10.1186/s42466-024-00334-3
pii: 10.1186/s42466-024-00334-3
doi:
Banques de données
ClinicalTrials.gov
['NCT05984056']
Types de publication
Journal Article
Langues
eng
Pagination
39Subventions
Organisme : Ohio Department of Higher Education
ID : ODHE2212PV
Informations de copyright
© 2024. The Author(s).
Références
Feigin, V. L., Vos, T., Alahdab, F., Amit, A. M. L., Bärnighausen, T. W., Beghi, E. (2021). Burden of Neurological Disorders Across the US From 1990–2017. JAMA Neurol [Internet]. ;78(2):165. https://jamanetwork.com/journals/jamaneurology/fullarticle/27725792 .
Ding, C., Wu, Y., Chen, X., Chen, Y., Wu, Z., Lin, Z. (2022). Global, regional, and national burden and attributable risk factors of neurological disorders: The Global Burden of Disease study 1990–2019. Front Public Health [Internet]. ;10. https://www.frontiersin.org/articles/ https://doi.org/10.3389/fpubh.2022.952161/full .
Suárez-Iglesias, D., Santos, L., Sanchez-Lastra, M. A., & Ayán, C. (2022). Systematic review and meta-analysis of randomised controlled trials on the effects of yoga in people with Parkinson’s disease (Vol. 44, pp. 6210–6229). Taylor and Francis Ltd. Disability and Rehabilitation.
Raglio, A., Attardo, L., Gontero, G., Rollino, S., Groppo, E., & Granieri, E. (2015). Effects of music and music therapy on mood in neurological patients. World J Psychiatry, 5(1), 68–78.
doi: 10.5498/wjp.v5.i1.68
pubmed: 25815256
pmcid: 4369551
Leung, I. H., Walton, C. C., Hallock, H., Simon Lewis, M. J., Valenzuela, M., & Lampit, A. (2015). Cognitive training in Parkinson disease: A systematic review and meta-analysis. Neurology, 85(21), 1843–1851.
doi: 10.1212/WNL.0000000000002145
pubmed: 26519540
pmcid: 4662707
Zucchella, C., Sinforiani, E., Tamburin, S., Federico, A., Mantovani, E., Bernini, S., et al. (2018). The Multidisciplinary Approach to Alzheimer’s Disease and Dementia. A narrative review of Non-pharmacological Treatment (Vol. 9). Frontiers Media S.A. Frontiers in Neurology.
Bleibel, M., El Cheikh, A., Sadier, N. S., & Abou-Abbas, L. (2023). The effect of music therapy on cognitive functions in patients with Alzheimer’s disease: A systematic review of randomized controlled trials (Vol. 15). BioMed Central Ltd. Alzheimer’s Research and Therapy.
Barnes, L. L., Dhana, K., Liu, X., Carey, V. J., Ventrelle, J., Johnson, K., et al. (2023). Trial of the MIND Diet for Prevention of Cognitive decline in older persons. New England Journal of Medicine, 389(7), 602–611.
doi: 10.1056/NEJMoa2302368
pubmed: 37466280
Feigin, V. L., Norrving, B., George, M. G., Foltz, J. L., Roth, G. A., & Mensah, G. A. (2016). Prevention of stroke: A strategic global imperative (Vol. 12, pp. 501–512). Nature Publishing Group. Nature Reviews Neurology.
Sarikaya, H., Ferro, J., & Arnold, M. (2015). Stroke prevention - medical and lifestyle measures. European Neurology, 73(3–4), 150–157.
doi: 10.1159/000367652
pubmed: 25573327
Yaffe, K., Vittinghoff, E., Dublin, S., Peltz, C. B., Fleckenstein, L. E., Rosenberg, D. E. (2023). Effect of Personalized Risk-Reduction Strategies on Cognition and Dementia Risk Profile Among Older Adults. JAMA Intern Med [Internet]. ; https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2811803 .
Cleveland Clinic Brain Study [Internet] https://my.clevelandclinic.org/departments/neurological/research-innovations/brain-study .
Gothe, N. P., & McAuley, E. (2015). Yoga and cognition: A Meta-analysis of chronic and Acute effects (Vol. 77, pp. 784–797). Lippincott Williams and Wilkins. Psychosomatic Medicine.
Sihvonen, A. J., Särkämö, T., Leo, V., Tervaniemi, M., Altenmüller, E., & Soinila, S. (2017). Music-based interventions in neurological rehabilitation (Vol. 16, pp. 648–660). Lancet Publishing Group. The Lancet Neurology.
Edwards, E., St Hillaire-Clarke, C., Frankowski, D. W., Finkelstein, R., Cheever, T., Chen, W. G., et al. (2023). NIH Music-based intervention toolkit: Music-based interventions for Brain disorders of Aging. Neurology, 100(18), 868–878.
doi: 10.1212/WNL.0000000000206797
pubmed: 36639235
pmcid: 10159759
Kivipelto, M., Mangialasche, F., & Ngandu, T. (2018). Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease (Vol. 14, pp. 653–666). Nature Publishing Group. Nature Reviews Neurology.
Mowszowski, L., Lampit, A., Walton, C. C., & Naismith, S. L. (2016). Strategy-based cognitive training for improving executive functions in older adults: A systematic review (Vol. 26, pp. 252–270). Springer New York LLC. Neuropsychology Review.
Chan, A. W., Tetzlaff, J. M., Gøtzsche, P. C., Altman, D. G., Mann, H., Berlin, J. A. (2013). SPIRIT 2013 explanation and elaboration: Guidance for protocols of clinical trials. Bmj. ;346.
Kural, M. A., Duez, L., Sejer Hansen, V., Larsson, P. G., Rampp, S., Schulz, R., et al. (2020). Criteria for defining interictal epileptiform discharges in EEG: A clinical validation study. Neurology, 94(20), E2139–E2147.
doi: 10.1212/WNL.0000000000009439
pubmed: 32321764
pmcid: 7526669